BioCryst Pharmaceuticals | 销售成本

Cost Of Sales 更改 日
Alnylam Pharmaceuticals USD 85.86M 1.55M 2023-12
Gilead Sciences USD 1.61B 46M 2023-12
Intra Cellular Therapies USD 10.7M 1.57M 2023-12
Ionis Pharmaceuticals USD 3.06M 871K 2023-12
Roche Holding CHF 7.62B 1.33B 2023-06
Ultragenyx Pharmaceutical USD 12.05M 1.06M 2023-12
Vertex Pharmaceuticals USD 318.7M 10.1M 2023-09



BioCryst Pharmaceuticals 销售成本 - 当前值，历史数据，预测，统计，图表和经济日历 - May 2024.